Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review

The antimicrobial drugs currently used for the management of tuberculosis (TB) exhibit poor bioavailability that necessitates prolonged treatment regimens and high dosing frequency to achieve optimal therapeutic outcomes. In addition, these agents cause severe adverse effects, as well as having detr...

詳細記述

書誌詳細

主要な著者:	Aristote B. Buya, Bwalya A. Witika, Alain M. Bapolisi, Chiluba Mwila, Grady K. Mukubwa, Patrick B. Memvanga, Pedzisai A. Makoni, Christian I. Nkanga
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2021-11-01
シリーズ:	Pharmaceutics
主題:	tuberculosis antimicrobial resistance lipid-based nanocarriers drug delivery nanomedicines
オンライン･アクセス:	https://www.mdpi.com/1999-4923/13/12/2041
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!